This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer or Fatigue
and you are
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to fatigue. PURPOSE: This research study is looking at biological markers of fatigue in women with residual invasive breast cancer enrolled on clinical trial NSABP-B-45.

Provided treatments

  • Genetic: gene expression analysis
  • Genetic: microarray analysis
  • Genetic: polymerase chain reaction
  • Genetic: polymorphism analysis
  • Genetic: reverse transcriptase-polymerase chain reaction
  • Other: biologic sample preservation procedure
  • Other: enzyme-linked immunosorbent assay
  • Other: laboratory biomarker analysis
  • Procedure: fatigue assessment and management
Tris trial is registered with FDA with number: NCT00914043. The sponsor of the trial is NSABP Foundation Inc and it is looking for 0 volunteers for the current phase.
Official trial title:
Biobehavioral Mechanisms of Fatigue in Patients Treated on NSABP B-45: A Phase III Clinical Trial Comparing Adjuvant Sunitinib Malate to Placebo in Women With Residual Invasive Breast Cancer Following Neoadjuvant Chemotherapy